179 related articles for article (PubMed ID: 31078451)
1. Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials.
Janes H; Donnell D; Gilbert PB; Brown ER; Nason M
Lancet HIV; 2019 Jul; 6(7):e475-e482. PubMed ID: 31078451
[TBL] [Abstract][Full Text] [Related]
2. HIV topical microbicides: steer the ship or run aground.
Gross M
Am J Public Health; 2004 Jul; 94(7):1085-9. PubMed ID: 15226123
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the design of HIV prevention trials in the United States.
Donnell D; Hughes JP; Fleming TR
J Acquir Immune Defic Syndr; 2010 Dec; 55 Suppl 2(Suppl 2):S136-40. PubMed ID: 21406984
[TBL] [Abstract][Full Text] [Related]
4. Control groups for HIV prevention efficacy trials: what does the future hold?
Janes H; Buchbinder S
Curr Opin HIV AIDS; 2023 Nov; 18(6):349-356. PubMed ID: 37712852
[TBL] [Abstract][Full Text] [Related]
5. In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities.
Janes H; Gilbert P; Buchbinder S; Kublin J; Sobieszczyk ME; Hammer SM
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1513-23. PubMed ID: 23597282
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on Design Approaches for HIV Prevention Efficacy Trials.
Prudden HJ; Tatoud R; Janes H; Wallace S; Miller V; Bekker LG; Donnell D
AIDS Res Hum Retroviruses; 2024 May; 40(5):301-307. PubMed ID: 37392020
[TBL] [Abstract][Full Text] [Related]
7. Oral pre-exposure prophylaxis for HIV prevention.
García-Lerma JG; Paxton L; Kilmarx PH; Heneine W
Trends Pharmacol Sci; 2010 Feb; 31(2):74-81. PubMed ID: 19963288
[TBL] [Abstract][Full Text] [Related]
8. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
[TBL] [Abstract][Full Text] [Related]
9. The future of HIV prevention.
Padian NS; Isbell MT; Russell ES; Essex M
J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 2():S22-6. PubMed ID: 22772385
[TBL] [Abstract][Full Text] [Related]
10. Creating effective partnerships for HIV prevention trials: report of a UNAIDS Consultation, Geneva 20-21 June 2005.
UNAIDS
AIDS; 2006 Apr; 20(6):W1-11. PubMed ID: 16549961
[TBL] [Abstract][Full Text] [Related]
11. Innovative Strategies for Scale up of Effective Combination HIV Prevention Interventions in Sub-Saharan Africa.
Shanaube K; Bock P
Curr HIV/AIDS Rep; 2015 Jun; 12(2):231-7. PubMed ID: 25929960
[TBL] [Abstract][Full Text] [Related]
12. Integrating behavioral and biomedical research in HIV interventions: challenges and opportunities.
Rausch DM; Grossman CI; Erbelding EJ
J Acquir Immune Defic Syndr; 2013 Jun; 63 Suppl 1():S6-11. PubMed ID: 23673890
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.
Dawson L; Zwerski S
Bioethics; 2015 Jun; 29(5):316-23. PubMed ID: 25230397
[TBL] [Abstract][Full Text] [Related]
14. Microbicides for prevention of HIV infection: clinical efficacy trials.
Abdool Karim SS; Baxter C
Curr Top Microbiol Immunol; 2014; 383():97-115. PubMed ID: 23695725
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
16. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
17. Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography.
Eakle R; Bourne A; Jarrett C; Stadler J; Larson H
BMC Public Health; 2017 Dec; 17(1):968. PubMed ID: 29258455
[TBL] [Abstract][Full Text] [Related]
18. An implementation science protocol of the Women's Health CoOp in healthcare settings in Cape Town, South Africa: A stepped-wedge design.
Wechsberg WM; Ndirangu JW; Speizer IS; Zule WA; Gumula W; Peasant C; Browne FA; Dunlap L
BMC Womens Health; 2017 Sep; 17(1):85. PubMed ID: 28923034
[TBL] [Abstract][Full Text] [Related]
19. Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.
Chang LW; Serwadda D; Quinn TC; Wawer MJ; Gray RH; Reynolds SJ
Lancet Infect Dis; 2013 Jan; 13(1):65-76. PubMed ID: 23257232
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
